Supernus Announces Pricing of Public Offering

[at noodls] – ROCKVILLE, Md., Nov. 29, 2012 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq:SUPN), a specialty pharmaceutical company announced the pricing of the underwritten public offering of 6,000,000 … more

View todays social media effects on SUPN

View the latest stocks trending across Twitter. Click to view dashboard